Rain Therapeutics Inc. (NASDAQ:RAIN) Q2 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Rain Oncology Inc. Second Quarter 2023 Earnings Conference Call.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Meteora Capital Vikas Mittal | 638,287 | $1,621,249 | +69% | 0.12% |
| 2. | Dorset Management David M. Knott | 101,686 | $258,282 | 0.15% | |
| 3. | 611,776 | $127,861 | 0% | ||
| 4. | 412,078 | $86,124 | -27% | 0.01% | |
| 5. | Magnetar Capital Alec Litowitz And Ross Laser | 23,970 | $60,884 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.58 | 4,000 | $10,320.00 | 644,834 | 2025-05-22 | Filing | |
| $2.53 | 30,000 | $75,900.00 | 640,834 | 2025-05-21 | Filing | |
| $1.73 | 8,514 | $14,729.22 | 610,834 | 2025-05-20 | Filing | |
| $11.39 | 13,173 | $150,040.47 | 13,173 | 2025-02-06 | Filing | |
| $11.39 | 8,782 | $100,026.98 | 1,848,104 | 2024-12-31 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.78 | 4,787 | $27,668.86 | 10,247 | 2025-09-12 | Filing | |
| $5.80 | 398 | $2,308.40 | 15,034 | 2025-09-11 | Filing | |
| $5.55 | 215 | $1,193.25 | 15,432 | 2025-09-10 | Filing | |
| $5.24 | 1,917 | $10,045.08 | 15,647 | 2025-09-09 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 39,643 | $100,693 | 0% | |
| 2. | 34,512 | $87,660 | 0% | |
| 3. | 30,538 | $77,566 | 0% | |
| 4. | 23,970 | $60,884 | 0% | |
| 5. | 20,000 | $50,800 | 0% |